Latest Asx News

Elsight Limited reports a record 340% revenue surge to US$4.8 million in the first half of 2025, backed by a robust US$11.45 million contract backlog and a strategic A$60 million capital raise to fuel expansion.

Encounter Resources has appointed key experts to accelerate development of its Aileron niobium-rare earth project, advancing metallurgical testing and market engagement.

GenusPlus Group has won an additional $60 million contract extension from Western Power, reinforcing its role in expanding WA’s renewable energy transmission network.

Peregrine Gold has announced a major discovery of a high-grade Channel Iron Deposit spanning over 7.7km near established BHP iron ore operations in Western Australia, signaling a promising new chapter for the Newman Gold Project.

American West Metals reports significant copper sulphide discoveries and thick mineralised intersections at its Storm Copper Project in Nunavut, Canada, highlighting strong potential for resource expansion.

Syrah Resources has resumed production and shipping from its Balama Graphite Operation in Mozambique, marking a significant step in restoring normal operations after earlier disruptions.

Austco Healthcare reports robust FY25 growth with revenue climbing over 37% and EBITDA soaring by more than 54%, fueled by strong organic performance and key acquisitions.

First Au Limited has kicked off a significant 3,000-metre diamond drilling campaign at its Liberian Nimba Gold Project, following a detailed 21-day geological mapping program that identified promising new targets.

AdAlta Limited has prioritized two promising CAR-T cellular immunotherapy products for licensing agreements and successfully raised $1.3 million to support its strategic expansion. The company’s focused capital management and pipeline refinement signal a pivotal phase in its ‘East to West’ strategy.

Legend Mining has officially surrendered its tenure over the Rockford Joint Venture tenements, marking the conclusion of its partnership with IGO Limited on this significant exploration project.

Tetratherix Limited has marked a pivotal quarter with a $25 million ASX listing, an exclusive licensing agreement with Bio Optix for ophthalmic devices, and progress on FDA regulatory submissions for its prostate spacer product.

One Click Group Limited has outpaced its entire July 2024 revenue within the first 18 days of July 2025, defying a broader decline in tax lodgements and showcasing strong customer loyalty.